Collin Kim
Vermogen: 19 929 $ op 31-07-2026
Vermogen: 19 929 $ op 31-07-2026
Sang Goo Kim is currently Director at Biocure Technology, Inc. since 2015 and Vice President at Columbia Capital, Inc. since 2008.
Former positions include Independent Director at Gravis Energy Corp.
and Independent Director at First Atlantic Nickel & Cobalt Corp.
from 2015 to 2020.
Education includes an undergraduate degree from Korea University, conferred in 1990.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-07-2025 | 1.992.877 ( 9,86% ) | 19 929 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOCURE TECHNOLOGY INC. | Directeur/Bestuurslid | 28-08-2015 |
Columbia Capital, Inc.
Columbia Capital, Inc. Investment ManagersFinance Provides investment advisory services | Corporate Officer/Principal | 01-01-2008 |
| Bedrijven | Functie | Einde |
|---|---|---|
Gravis Energy Corp.
Gravis Energy Corp. Other Metals/MineralsNon-Energy Minerals Explores and develops uranium, natural resources | Directeur/Bestuurslid | - |
| FIRST ATLANTIC NICKEL & COBALT CORP. | Algemeen Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
First Atlantic Nickel Corp.
First Atlantic Nickel Corp. Other Metals/MineralsNon-Energy Minerals Engages in the acquisition, evaluation, exploration, and development of oil, gas, and mineral resources | Non-Energy Minerals |
Korea University
Korea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gravis Energy Corp.
Gravis Energy Corp. Other Metals/MineralsNon-Energy Minerals Explores and develops uranium, natural resources | Non-Energy Minerals |
Columbia Capital, Inc.
Columbia Capital, Inc. Investment ManagersFinance Provides investment advisory services | Finance |
Biocure Technology, Inc.
Biocure Technology, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau